5-chloropyrazinamide has been researched along with Koch's Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, M; Jacobs, WR; Vilchèze, C; Welch, JT; Zimhony, O | 1 |
| Ahmad, Z; Almeida, D; Baughn, AS; Grosset, JH; Jacobs, WR; Minkowsk, A; Nuermberger, EL; Peck, KM; Tyagi, S; Welch, JT | 1 |
2 other study(ies) available for 5-chloropyrazinamide and Koch's Disease
| Article | Year |
|---|---|
Pyrazinoic acid and its n-propyl ester inhibit fatty acid synthase type I in replicating tubercle bacilli.
Topics: Bacterial Proteins; Fatty Acid Synthases; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Structure-Activity Relationship; Tuberculosis | 2007 |
Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
Topics: Animals; Antitubercular Agents; Female; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium bovis; Mycobacterium tuberculosis; Pyrazinamide; Tuberculosis | 2012 |